HARBINGER STRATEGIES, LLC

Lobbying for GENENTECH, INC. · Biotech company developing medicines to treat patients.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Taxation/Internal Revenue Code

Issues related to corporate taxation including corporate rate; deductibility of research and development expenses; and international taxation (Foreign Derived Intangible Income). P.L. 119-21.

Health Issues

Issues related to drug pricing. Issues related to the 340B Drug Discount Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.